Rethinking Prognosis and Therapy for Follicular Lymphoma

J Clin Oncol. 2015 Aug 10;33(23):2489-91. doi: 10.1200/JCO.2015.62.3256. Epub 2015 Jul 13.

Authors

Caron A Jacobson¹, Arnold S Freedman²

Affiliations

¹ Dana-Farber Cancer Institute; and Harvard Medical School, Boston, MA cajacobson@partners.org.
² Dana-Farber Cancer Institute; and Harvard Medical School, Boston, MA.

PMID: 26169620
DOI: 10.1200/JCO.2015.62.3256

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Female
Humans
Lymphoma, Follicular / drug therapy*
Lymphoma, Follicular / mortality*
Male
Neoplasm Recurrence, Local / drug therapy*
Neoplasm Recurrence, Local / mortality*